A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
Pfizer
Pfizer
Genmab
Fate Therapeutics
Actuate Therapeutics Inc.
Novartis
Eisai Inc.
Pfizer
Neonc Technologies, Inc.
AstraZeneca
Enliven Therapeutics
Incyte Corporation
Incyte Corporation
Toray Industries, Inc
Shanghai Junshi Bioscience Co., Ltd.
DEKA Biosciences
National Institutes of Health Clinical Center (CC)
GI Innovation, Inc.
Eli Lilly and Company
National University Hospital, Singapore
AbbVie
Canadian Cancer Trials Group
Nektar Therapeutics
Incyte Corporation
Gilead Sciences
Rutgers, The State University of New Jersey